These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 18335425)
1. Delivery of peptides to the brain: emphasis on therapeutic development. Banks WA Biopolymers; 2008; 90(5):589-94. PubMed ID: 18335425 [TBL] [Abstract][Full Text] [Related]
2. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Pardridge WM Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095 [TBL] [Abstract][Full Text] [Related]
3. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Löscher W; Potschka H Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870 [TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Kinoshita M; McDannold N; Jolesz FA; Hynynen K Biochem Biophys Res Commun; 2006 Feb; 340(4):1085-90. PubMed ID: 16403441 [TBL] [Abstract][Full Text] [Related]
6. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Begley DJ Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907 [TBL] [Abstract][Full Text] [Related]
8. Neuropeptides and the blood-brain barrier. Pardridge WM; Frank HJ; Cornford EM; Braun LD; Crane PD; Oldendorf WH Adv Biochem Psychopharmacol; 1981; 28():321-8. PubMed ID: 7010940 [TBL] [Abstract][Full Text] [Related]
9. Transport of nutrients and hormones through the blood-brain barrier. Pardridge WM Fed Proc; 1984 Feb; 43(2):201-4. PubMed ID: 6141071 [TBL] [Abstract][Full Text] [Related]
10. Delivery of therapeutic peptides and proteins to the CNS. Salameh TS; Banks WA Adv Pharmacol; 2014; 71():277-99. PubMed ID: 25307220 [TBL] [Abstract][Full Text] [Related]
11. Chapter 1 - Drug delivery to the brain using colloidal carriers. Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826 [TBL] [Abstract][Full Text] [Related]
12. The source of cerebral insulin. Banks WA Eur J Pharmacol; 2004 Apr; 490(1-3):5-12. PubMed ID: 15094069 [TBL] [Abstract][Full Text] [Related]
13. The blood-brain barrier as a regulatory interface in the gut-brain axes. Banks WA Physiol Behav; 2006 Nov; 89(4):472-6. PubMed ID: 16904139 [TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system. Allen DD; Geldenhuys WJ Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231 [TBL] [Abstract][Full Text] [Related]
15. Identification and design of peptides as a new drug delivery system for the brain. Demeule M; Régina A; Ché C; Poirier J; Nguyen T; Gabathuler R; Castaigne JP; Béliveau R J Pharmacol Exp Ther; 2008 Mar; 324(3):1064-72. PubMed ID: 18156463 [TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain. Pardridge WM Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518 [TBL] [Abstract][Full Text] [Related]
17. Transport of nutrients and hormones through the blood-brain barrier. Pardridge WM Diabetologia; 1981 Mar; 20 Suppl():246-54. PubMed ID: 7014323 [TBL] [Abstract][Full Text] [Related]
18. Permeability of the blood-brain barrier to HIV-1 Tat. Banks WA; Robinson SM; Nath A Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280 [TBL] [Abstract][Full Text] [Related]
19. Drug delivery to the CNS and polymeric nanoparticulate carriers. Costantino L Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839 [TBL] [Abstract][Full Text] [Related]
20. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. Banks WA; Tschöp M; Robinson SM; Heiman ML J Pharmacol Exp Ther; 2002 Aug; 302(2):822-7. PubMed ID: 12130749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]